WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomas

Christopher J. Douglas(University of Minnesota), Daniela A. Bota(University of California, Irvine)

bioRxiv (Cold Spring Harbor Laboratory)

April 17, 2023

10.1101/2023.04.13.536816

Cited by 2

Related Papers

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

|Journal of Translational Medicine|2018|540

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

|JAMA Oncology|2022|411

Non-viral precision T cell receptor replacement for personalized cell therapy

|Nature|2022|276

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma

|JAMA Oncology|2020|141

Sequential 1,2-Addition−Electrocyclic Ring Closures Involving Acyclic α,β-Unsaturated Iminiums: A Formal [3 + 3] Cycloaddition Strategy to Unique Pyranyl Spirocycles

|The Journal of Organic Chemistry|1999|89